Ποια είναι η τιμή για PCL, Inc. (241820)

Η τιμή για PCL, Inc. (241820) είναι $0.21291741

Ποια είναι η κεφαλαιοποίηση αγοράς για PCL, Inc. (241820)

Η κεφαλαιοποίηση αγοράς για PCL, Inc. (241820) είναι $12.07M

PCL, Inc. (241820) Τιμή και Κεφαλαιοποίηση Αγοράς

PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic (IVD) solutions, encompassing both diagnostic products and specialized platform services. The company's primary offerings include comprehensive multiplex kits designed to detect antibodies to Human Immunodeficiency Virus (HIV) types 1 and 2, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human T-lymphotropic Virus (HTLV) types 1 and 2. These kits also identify specific antigens such as HIV p24, HCV core, and HBV surface markers in human serum or plasma samples. In addition to these, PCL markets Ai, a rapid diagnostic test kit capable of typing influenza A and B strains; Cancer6, a screening kit for multiple tumor biomarkers; and the sciLINER LATERAL FLOW DISPENSER, an advanced dispensing device for membrane materials featuring active visual drop volume control. Beyond its product portfolio, PCL offers valuable platform services. These include a sol-gel spotting service, which immobilizes client-specified materials using the proprietary SolB reagent, and an SG ID service, providing customers with identified molecules of interest securely immobilized within the SolB reagent. PCL, Inc. is headquartered in Seoul, South Korea.

Η τιμή για 241820	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$96,338.45 $12.07M	NVDA	$5.460T	+45,246,766.19%
$79,212.25 $12.07M	AAPL	$4.489T	+37,203,175.41%
$73,061.69 $12.07M	GOOG	$4.141T	+34,314,470.41%
$62,963.04 $12.07M	MSFT	$3.569T	+29,571,481.47%
$49,368.30 $12.07M	AMZN	$2.798T	+23,186,495.93%

Η τιμή για 241820

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$96,338.45 $12.07M